UK's Genome Ethics Effort Aims to Determine What Genomic Data Should Be Reported to Study Participants | GenomeWeb

Millions of whole-genome genotyping arrays have been run as part of various studies over the past decade, but how much information obtained from genome-wide scans should be reported to study participants?

Researchers at the Wellcome Trust Sanger Institute in Hinxton, UK, plan to find out through a project called Genome Ethics. The aim of the study is to gather empirical data to help guide policy decision-making on the sharing of findings from whole-genome research studies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.